Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 Signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 Signaling
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fphar.2021.774709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAMPT/SIRT1 Attenuate Ang II-Induced Vascular Remodeling and Vulnerability to Hypertension by Inhibiting the ROS/MAPK Pathway
- (2021) Lei Zhou et al. Oxidative Medicine and Cellular Longevity
- Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
- (2021) Dahu Qi et al. Frontiers in Pharmacology
- An Antioxidant Sesquiterpene Inhibits Osteoclastogenesis Via Blocking IPMK/TRAF6 and Counteracts OVX‐ Induced Osteoporosis in Mice
- (2021) Shiyu Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Azilsartan prevented AGE‐induced inflammatory response and degradation of aggrecan in human chondrocytes through inhibition of Sox4
- (2021) Jie Lei et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1–Nrf2 signalling pathway
- (2021) Ning Hou et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Effects of the Local Bone Renin-Angiotensin System on Titanium-Particle-Induced Periprosthetic Osteolysis
- (2021) Zhiping Zhao et al. Frontiers in Pharmacology
- Nicorandil Inhibits Osteoclast Formation Base on NF-κB and p-38 MAPK Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
- (2021) Shenggui Xu et al. Frontiers in Pharmacology
- Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling
- (2020) Shuo Ni et al. CELL PROLIFERATION
- RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target
- (2020) Masashi Honma et al. PHARMACOLOGY & THERAPEUTICS
- Bone Metastasis: Mechanisms, Therapies and Biomarkers
- (2020) Philippe Clezardin et al. PHYSIOLOGICAL REVIEWS
- Azilsartan Suppressed LPS-Induced Inflammation in U937 Macrophages through Suppressing Oxidative Stress and Inhibiting the TLR2/MyD88 Signal Pathway
- (2020) Qinglian Dong et al. ACS Omega
- NRF2 function in osteocytes is required for bone homeostasis and drives osteocytic gene expression
- (2020) Cristina Sánchez-de-Diego et al. Redox Biology
- The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice
- (2019) Xiangde Zhao et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway
- (2019) Lin Zheng et al. FASEB JOURNAL
- Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases
- (2019) Taiwo Samuel Agidigbi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AT1R-Mediated Apoptosis of Bone Marrow Mesenchymal Stem Cells Is Associated with mtROS Production and mtDNA Reduction
- (2019) Fenxi Zhang et al. Oxidative Medicine and Cellular Longevity
- The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling
- (2019) Xuewu Sun et al. Redox Biology
- Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk
- (2018) Sameh Saber et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid
- (2017) Ee Min Tan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Low shear stress induces endothelial reactive oxygen species via the AT1R/eNOS/NO pathway
- (2017) Yuelin Chao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Azilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activity
- (2016) Hao Liu et al. NEUROCHEMISTRY INTERNATIONAL
- Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system
- (2015) Matthew C. Walsh et al. IMMUNOLOGICAL REVIEWS
- Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice
- (2014) Sachiko Matsumoto et al. Cardiovascular Diabetology
- Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes
- (2014) Mohammed Abdelsaid et al. Translational Research
- Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation
- (2013) Seungha Hyeon et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species Signaling
- (2013) Hiroyuki Kanzaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of estrogen and androgen receptors in bone health and disease
- (2013) Stavros C. Manolagas et al. Nature Reviews Endocrinology
- The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study
- (2013) Jennifer A Knopp-Sihota et al. BMC Geriatrics
- Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
- (2012) Aurelie Nguyen Dinh Cat et al. ANTIOXIDANTS & REDOX SIGNALING
- Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2 Akita diabetic mice
- (2011) Hiroki Fujita et al. HYPERTENSION RESEARCH
- Physiological function of the angiotensin AT1a receptor in bone remodeling
- (2011) Keiko Kaneko et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of NF-κB in the skeleton
- (2010) Deborah Veis Novack CELL RESEARCH
- Angiotensin II revisited: new roles in inflammation, immunology and aging
- (2010) Ariela Benigni et al. EMBO Molecular Medicine
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
- (2010) Stavros C. Manolagas ENDOCRINE REVIEWS
- Receptor activator of nuclear factor-κB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues
- (2009) Hideyuki Sasaki et al. FREE RADICAL BIOLOGY AND MEDICINE
- Disruption of the Ang II type 1 receptor promotes longevity in mice
- (2009) Ariela Benigni et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of Renin–Angiotensin System Induces Osteoporosis Independently of Hypertension
- (2008) Yutaro Asaba et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer
- (2008) T. Boutros et al. PHARMACOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now